A new era in Alzheimer’s treatment
January 11, 2023
…if this option is suitable for them. ———– More information about the AHEAD study is available at the study page on the Glenn Biggs Institute website. This page contains a…
January 11, 2023
…if this option is suitable for them. ———– More information about the AHEAD study is available at the study page on the Glenn Biggs Institute website. This page contains a…
January 11, 2023
…with eligible patients to discuss if this option is suitable for them. More information about the AHEAD study is available at the study page on the Glenn Biggs Institute website….
December 12, 2022
Attracting great people is an essential part of our five-year strategic plan. There are two tenets, or organizing and operational principles, that we focus on that are foundational to…
December 8, 2022
The AHEAD clinical trial will assess whether the new Alzheimer’s drug, lecanemab, can delay the onset of dementia in persons who are at high risk of developing the disease. …
December 1, 2022
…Glenn Biggs Institute website. This page contains a list of eligibility criteria and a YouTube video introduction to the study. To inquire about screening for the trial, contact Amy Saklad,…
October 27, 2022
The third season of Texas Public Radio’s podcast, “Twenty-Four Seven: A Podcast About Caregiving,” premiered this September hosted by National Public Radio journalist Kitty Eisele. Eisele, also an Emmy…